Antiviral product, use and formulation thereof

Details Antiviral product, use and formulation thereof Antiviral product, use and formulation thereof

2006-01-10

2006-01-10

Page, Thurman K. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S400000, C424S451000, C424S464000, C424S490000, C424S492000, C424S497000, C424S502000

Reexamination Certificate

active

06984401

ABSTRACT:
An antiviral product is comprised of at least three dosages forms, each of which has a different release profile, with the Cmaxfor the antiviral product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosage form, as well as two or more delayed release dosage forms, with each of the dosage forms having a different release profile, wherein each reaches a Cmaxat different times.

REFERENCES:
patent: 4435173 (1984-03-01), Siposs et al.
patent: 4616008 (1986-10-01), Hirai et al.
patent: 4794001 (1988-12-01), Mehta et al.
patent: 4831025 (1989-05-01), Godtfredsen et al.
patent: 4904476 (1990-02-01), Mehta et al.
patent: 4915953 (1990-04-01), Jordan et al.
patent: 4971805 (1990-11-01), Kitanishi et al.
patent: 5011692 (1991-04-01), Fujioka et al.
patent: 5110597 (1992-05-01), Wong et al.
patent: 5213808 (1993-05-01), Bar-Shalom et al.
patent: 5229131 (1993-07-01), Amidon et al.
patent: 5395626 (1995-03-01), Kotwal et al.
patent: 5401512 (1995-03-01), Rhodes et al.
patent: 5413777 (1995-05-01), Sheth et al.
patent: 5414014 (1995-05-01), Schneider et al.
patent: 5445829 (1995-08-01), Paradissis et al.
patent: 5462747 (1995-10-01), Radebaugh et al.
patent: 5472708 (1995-12-01), Chen
patent: 5508040 (1996-04-01), Chen
patent: 5538954 (1996-07-01), Koch et al.
patent: 5567441 (1996-10-01), Chen
patent: 5672359 (1997-09-01), Digenis et al.
patent: 5719132 (1998-02-01), Lin et al.
patent: 5827531 (1998-10-01), Morrison et al.
patent: 5840329 (1998-11-01), Bai
patent: 5877243 (1999-03-01), Sarangapani
patent: 5883079 (1999-03-01), Zopf et al.
patent: 5910322 (1999-06-01), Rivett et al.
patent: 6027748 (2000-02-01), Conte et al.
patent: 6068859 (2000-05-01), Curatolo et al.
patent: 6120803 (2000-09-01), Wong et al.
patent: 6132771 (2000-10-01), Depui et al.
patent: 6294199 (2001-09-01), Conley et al.
patent: 6358525 (2002-03-01), Guo et al.
patent: 6541014 (2003-04-01), Rudnic et al.
patent: 6544555 (2003-04-01), Rudnic et al.
patent: 6565882 (2003-05-01), Rudnic
patent: 2001/0046984 (2001-11-01), Rudnic et al.
patent: 2001/0048944 (2001-12-01), Rudnic et al.
patent: 2002/0004070 (2002-01-01), Rudnic et al.
patent: 2002/0004499 (2002-01-01), Rudnic et al.
patent: 2002/0068078 (2002-06-01), Rudnic et al.
patent: 2002/0068085 (2002-06-01), Rudnic et al.
patent: 2002/0119168 (2002-08-01), Rudnic et al.
patent: 2002/0136764 (2002-09-01), Rudnic et al
patent: 2002/0136765 (2002-09-01), Rudnic et al.
patent: 2002/0136766 (2002-09-01), Rudnic et al.
patent: 2002/0150619 (2002-10-01), Rudnic et al.
patent: 2002/0197314 (2002-12-01), Rudnic et al.
patent: 2003/0012814 (2003-01-01), Rudnic et al.
patent: 2003/0066410 (2003-04-01), Rudnic et al.
patent: 2003/0077323 (2003-04-01), Rudnic et al.
patent: 2003/0086969 (2003-05-01), Rudnic et al.
patent: 2003/0096006 (2003-05-01), Rudnic et al.
patent: 2003/0096007 (2003-05-01), Rudnic et al.
patent: 2003/0096008 (2003-05-01), Rudnic et al.
patent: 2003/0099706 (2003-05-01), Rudnic et al.
patent: 2003/0099707 (2003-05-01), Rudnic et al.
patent: 2003/0104054 (2003-06-01), Rudnic et al.
patent: 2003/0104055 (2003-06-01), Rudnic et al.
patent: 2003/0104056 (2003-06-01), Rudnic et al.
patent: 2003/0104058 (2003-06-01), Rudnic et al.
patent: 0652008 (1995-05-01), None
patent: WO 94/27557 (1994-12-01), None
patent: WO 95/20946 (1995-08-01), None
patent: WO 96/04908 (1996-02-01), None
patent: WO 98/22091 (1998-05-01), None
Erah et al.; The Stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment ofHelibacter pyloriinfection.; Jan. 1997; Journal of Antimicrob. Chemother. 39(1):5-12. PMID: 9044021.
Yousef et al.: Combined action of amoxycillin and dicloxicillin againstStaphylococcus aureusin vitro; Sep. 1985; Pharmazie; 40(9):650-1 PMID: 3877939.
Gnarpe et al.; Pencillin combinations against multi-resistant urinary pathogens as an alternative to gentamycin treatment; 1976; Microbios.; 16(65-66):201-6 PMID: 18651.

Affiliated with

Also associated with

Rating

Antiviral product, use and formulation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral product, use and formulation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral product, use and formulation thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3602713